Global Fertility Treatment Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 32.30 Billion |
| Market Size (2029) | USD 45.70 Billion |
| CAGR (2024 - 2029) | 7.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Global Fertility Treatment Market Analysis
The Global Fertility Treatment Market size is estimated at USD 32.30 billion in 2024, and is expected to reach USD 45.70 billion by 2029, growing at a CAGR of 7.20% during the forecast period (2024-2029).
The rising incidence of various gynecological disorders such as uterine issues, delayed onset of pregnancies in women, and fallopian tube issues drives the leveraging growth of the fertility treatment market. Also, there is a sudden surge in infertility in men all over the world due to changing lifestyles, genetic defects, health problems such as diabetes, or infections such as chlamydia, gonorrhea, mumps, and HIV.
For the past several years, there has been a huge decline in the fertility rate around the globe. The fertility rate is generally associated with the average number of children born to women during their reproductive years. For the population in each area to remain stable, an overall total fertility rate of 2.1 is needed, assuming no immigration or emigration occurs. In 2023, Japan's total fertility rate, which measures the number of children a woman has in her lifetime, dropped for the eighth consecutive year. According to demographic statistics published in June 2024 by the Ministry of Health, Labor, and Welfare, the rate reached a record low of 1.20, marking a Y-o-Y decline of 0.06 points. As the total fertility rate declines, more couples may experience difficulties conceiving naturally, leading to an increased demand for fertility treatments such as in vitro fertilization (IVF) and other ART procedures. This drives the market growth during the forecast period.
In addition, rising technological development in treatment approaches, increasing awareness, and growing healthcare infrastructure will help the market grow during the forecast period. At the beginning of 2024, Adore Fertility of the United States stated that the clinic was focused on identifying epigenetic markers that could predict a patient’s response to fertility treatments. By understanding these markers, doctors can customize treatment protocols to optimize success rates.
Hence, dropping the fertility rate and increasing the focus of fertility service providers on developing new advanced treatment approaches are likely to drive the market during the forecast period.
However, the high cost of the procedure, potential risks and complications, and stringent regulatory framework may hinder the market's growth.
Global Fertility Treatment Market Trends
The In Vitro Fertilization Segment is Expected to Dominate the Market During The Forecast Period
The in vitro fertilization segment plays a significant role in the fertility treatment market due to the specialized nature of the treatment, which brings more success in parenthood. Based on the treatment type, the in vitro fertilization (IVF) segment dominates the market share and is expected to do so even during the forecast period. The increasing incidence of infertility cases, the emerging trend of delayed pregnancies among women, rising awareness about the benefits of IVF, and increased occurrences of gamete donations are some of the factors that support the growth of the market.
Recent developments in IVF technology or technique, such as embryoscope, capsule IVF, cryopreservation, or fertility preservation, are also anticipated to augment the demand for IVF treatment. For instance, in May 2024, Gameto, a biotechnology company developing new fertility treatments, raised USD 33 million in venture capital funding to support research and development. The new treatment technology could shorten in vitro fertilization cycles and replace the hormonal injections used in IVF.
Moreover, the increasing focus of diagnosis companies on developing innovative products to support successful IVF outcomes is also a factor that drives the segment. In December 2023, reproductive technology company Orchid launched the first commercially available whole genome sequencing test for embryos. The test can identify a child’s birth defects and adult-onset cancers before an IVF pregnancy begins. This development provides a significant boost to the IVF segment.
Therefore, these developments have focused on introducing innovative technologies and launching new diagnostic products to facilitate more successful IVF, leading to exponential growth.
North America is Expected to Hold the Largest Market Share
North America dominates the fertility treatment market and is expected to maintain its legacy even during the forecast period. This is attributed to the increase in infertility cases due to rising hormonal disorders, obesity, and unhealthy lifestyle habits. For instance, according to a report published by the Endocrine Society in January 2022, Polycystic Ovary Syndrome affects 7%-10% of women of childbearing age and is the most common cause of infertility. In the United States, an estimated 5 to 6 million women have polycystic ovary syndrome.
Moreover, the increasing adoption of various business strategies, such as acquisitions and partnerships by the companies, increases the introduction of advanced fertility treatment centers and options, which is anticipated to propel market growth. For instance, in July 2023, CCRM Fertility launched a state-of-the-art clinic and in vitro fertilization (IVF) lab in Miami to meet the increasing demand for world-class fertility care and comprehensive family-building benefits by patients and employers.
Additionally, supportive government initiatives that provide financial assistance in fertility treatment are a factor that drives the market in the region. In February 2024, the British Columbia government in Canada announced that it would start covering one cycle of in vitro fertilization (IVF) as part of the 2024/2025 budget, beginning on April 1, 2025.
The market in North America is growing due to the increasing prevalence of hormonal disorders leading to rising infertility. Government support and strategic initiatives by service providers, such as opening fertility clinics, are driving this growth. This growth is also supported by rising per capita income and increasing healthcare expenditure.
Global Fertility Treatment Industry Overview
Pfizer Inc., Teva Pharmaceuticals Industries Ltd, Sanofi SA, Ferring Holdings SA, Virtus Health, San Diego Fertility Center, and some major product and service providers are leading companies operating in the fertility treatment market. The leading market companies constantly focus on providing technologically advanced products, increasing global footprints, and strategic partnerships to keep their head high in a competitive market.
Global Fertility Treatment Market Leaders
-
Merck KGaA
-
Pfizer, Inc.
-
Teva Pharmaceuticals Industries Ltd
-
San Diego Fertility Center
-
Virtus Health
*Disclaimer: Major Players sorted in no particular order
Global Fertility Treatment Market News
- August 2024: Alchemist Group of Hospitals announced the launch of its state-of-the-art infertility treatment and IVF services center in Panchkula, India.
- February 2024: Lupin Limited launched infertility treatment medicine Ganirelix acetate injection, 250 mcg/0.5 mL, single-dose prefilled in the United States. It is indicated to inhibit premature luteinizing hormone (LH) surges in women undergoing controlled ovarian hyperstimulation.
Global Fertility Treatment Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Global Prevalence of Gynecological Diseases
4.2.2 Advancement in Fertility Treatment
4.3 Market Restraints
4.3.1 High Cost of Treatment
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Gender
5.1.1 Female Infertility
5.1.2 Male Infertility
5.2 By Treatment
5.2.1 In-vitro fertilization (IVF)
5.2.2 Intrauterine insemination (IUI)
5.2.3 Artificial Insemination
5.2.4 Infertility Drugs
5.2.5 Surgery
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Pfizer Inc.
6.1.2 Teva Pharmaceuticals Industries Ltd
6.1.3 Sanofi SA
6.1.4 Ferring Holdings SA
6.1.5 Sun Pharma Limited
6.1.6 Virtus Health
6.1.7 San Diego Fertility Center
6.1.8 VivaNeo
6.1.9 Bloom IVF Group
6.1.10 IHR Clinic
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Global Fertility Treatment Industry Segmentation
Fertility treatments are medical services and products (drugs) that help couples who want to become parents but have been unable to do so naturally due to medical reasons. These fertility services assist single individuals, the LGBT community, and infertile couples in starting a family. Fertility services involve several techniques and procedures that are used for treating genetic issues and infertility problems to help in conception. The market covers services and drugs for the treatment of infertility in males and females.
The fertility treatment market is segmented by gender and treatment. In terms of gender, the market is segmented into female infertility and male infertility. By treatment, the market is segmented into in vitro fertilization, intrauterine insemination (IUI), infertility drugs, and surgery. In terms of geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market report covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers market size and forecasts in value (USD) for the above segments.
| By Gender | |
| Female Infertility | |
| Male Infertility |
| By Treatment | |
| In-vitro fertilization (IVF) | |
| Intrauterine insemination (IUI) | |
| Artificial Insemination | |
| Infertility Drugs | |
| Surgery |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Fertility Treatment Market Research FAQs
How big is the Global Fertility Treatment Market?
The Global Fertility Treatment Market size is expected to reach USD 32.30 billion in 2024 and grow at a CAGR of 7.20% to reach USD 45.70 billion by 2029.
What is the current Global Fertility Treatment Market size?
In 2024, the Global Fertility Treatment Market size is expected to reach USD 32.30 billion.
Who are the key players in Global Fertility Treatment Market?
Merck KGaA, Pfizer, Inc., Teva Pharmaceuticals Industries Ltd, San Diego Fertility Center and Virtus Health are the major companies operating in the Global Fertility Treatment Market.
Which is the fastest growing region in Global Fertility Treatment Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Global Fertility Treatment Market?
In 2024, the North America accounts for the largest market share in Global Fertility Treatment Market.
What years does this Global Fertility Treatment Market cover, and what was the market size in 2023?
In 2023, the Global Fertility Treatment Market size was estimated at USD 29.97 billion. The report covers the Global Fertility Treatment Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Fertility Treatment Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Global Fertility Treatment Industry Report
Statistics for the 2024 Global Fertility Treatment market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Global Fertility Treatment analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
